Panel discussion: Improving the pathway of lung cancer patients, can we do it better?

A. Šajnic (Zagreb, Croatia), T. Blum (Berlin, Germany), Prof. Marko Jakopovic (Zagreb, Croatia), A. Breški (Zagreb, Croatia), I. Belina (Zagreb, Croatia), G. Hardavella (Athens, Greece), M. J. Catarata (Porto, Portugal)

Source: ERS webinar 2021: Panel discussion on improving the pathway of lung cancer patients, can we do it better?
Number: 0

Slide presentationWebcast

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Šajnic (Zagreb, Croatia), T. Blum (Berlin, Germany), Prof. Marko Jakopovic (Zagreb, Croatia), A. Breški (Zagreb, Croatia), I. Belina (Zagreb, Croatia), G. Hardavella (Athens, Greece), M. J. Catarata (Porto, Portugal). Panel discussion: Improving the pathway of lung cancer patients, can we do it better?. ERS webinar 2021: Panel discussion on improving the pathway of lung cancer patients, can we do it better?

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
EUELC project: a multi-centre, multipurpose study to investigate early stage NSCLC, and to establish a biobank for ongoing collaboration
Source: Eur Respir J 2009; 34: 1477-1486
Year: 2009



Reducing delays in lung cancer diagnostic pathways to improve patient experience
Source: International Congress 2016 – Quality management and quality of life in lung cancer
Year: 2016

Novel survey tool used to assess priorities of lung cancer patients and carers
Source: International Congress 2015 – Quality management in lung cancer
Year: 2015


The two week wait pathway: Is it used appropriately?
Source: International Congress 2014 – Epidemiology, pathogenesis and quality management of thoracic tumours
Year: 2014

Lung cancer survival in the UK: are the results from the national lung cancer audit (LUCADA) dependent on completeness of case reporting?
Source: Annual Congress 2009 - Epidemiology and management of lung cancer
Year: 2009


Oncogenic drivers (OD) and matched targeted agents (TA): Impact on overall survival in patients with lung adenocarcinoma (LA)?
Source: International Congress 2015 – Lung cancer: prognostic factors and features of oncogene-driven tumours
Year: 2015


Lung cancer screening: the critical review
Source: International Congress 2015 – Lung cancer screening: how to implement a comprehensive preventive approach
Year: 2015



Lung function in the elderly patients with a diagnosis of lung cancer - A challenge for the surgical treatment?
Source: International Congress 2015 – Surgery and lung cancer: results and complications
Year: 2015

Muldisciplinary conference (MDC), oncological program (OP) and practice guidelines (GL): The experience of the lung cancer (LC) clinic of a cancer hospital
Source: International Congress 2014 – Advances in diagnosis and therapy of thoracic tumours
Year: 2014



Improving NLST criteria for lung cancer screening
Source: International Congress 2014 – Improving diagnosis of thoracic tumours
Year: 2014


Is time from "referral to diagnosis" in lung cancer pathway affected by diagnostic test delays?
Source: International Congress 2015 – Quality management in lung cancer
Year: 2015

Active TB in cancer patients: A missed screening opportunity?
Source: International Congress 2015 – Screening strategies in TB
Year: 2015

Does bronchial location of lung cancer influence overall survival?
Source: International Congress 2015 – Lung cancer: prognostic factors and features of oncogene-driven tumours
Year: 2015

Do doctors understand the test characteristics of lung cancer screening? – A randomized trial
Source: International Congress 2016 – A view into a chest and pleural pathology
Year: 2016

Screening for lung cancer: who should (not) be enrolled?
Source: International Congress 2019 – NELSON: the Trafalgar of lung cancer screening?
Year: 2019


A network lung cancer pathway in review: Are we choosing the right diagnostic approach?
Source: Annual Congress 2010 - Quality management for lung cancer patients
Year: 2010


National lung cancer tissue diagnosis targets: Are they achievable?
Source: International Congress 2014 – Improving diagnosis of thoracic tumours
Year: 2014

COPD and lung cancer: Prevalence, infradiagnosis, phenotypes and multidimensional characterization
Source: International Congress 2016 – Epidemiology and specific subgroups in lung cancer
Year: 2016


Population’s understanding and degree of participation of a screening lung cancer programme
Source: International Congress 2015 – Quality management in lung cancer
Year: 2015